TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties

Published on Dec 4, 2020in Frontiers in Cell and Developmental Biology5.201
· DOI :10.3389/FCELL.2020.596831
Ghada Beldi2
Estimated H-index: 2
(French Institute of Health and Medical Research),
Sheyda Bahiraii1
Estimated H-index: 1
(University of Vienna)
+ 4 AuthorsSina Naserian10
Estimated H-index: 10
(French Institute of Health and Medical Research)
Mesenchymal stem cells (MSCs) have drawn lots of attention as gold standard stem cells in fundamental and clinical researches during the last 20 years. Due to their tissue and vascular repair capacities, MSCs have been used to treat a variety of degenerative disorders. Moreover, MSCs are able to modulate immune cells' functions, particularly T cells while inducing regulatory T cells (iTregs). MSCs are very sensitive to inflammatory signals. Their biological functions could remarkably vary after exposure to different pro-inflammatory cytokines, notably TNFα. In this article, we have explored the importance of TNFR2 expression in a series of MSCs' biological and functional properties. Thus, MSCs from wild-type (WT) and TNFR2 knockout (TNFR2 KO) mice were isolated and underwent several ex vivo experiments to investigate the biological significance of TNFR2 molecule in MSC main functions. Hampering in TNFR2 signaling resulted in reduced MSC colony-forming units and proliferation rate and diminished the expression of all MSC characteristic markers such as stem cell antigen-1 (Sca1), CD90, CD105, CD44, and CD73. TNFR2 KO-MSCs produced more pro-inflammatory cytokines like TNFα, IFNγ, and IL-6 and less anti-inflammatory mediators such as IL-10, TGFβ, and NO and induced Tregs with less suppressive effect. Furthermore, the TNFR2 blockade remarkably decreased MSC regenerative functions such as wound healing, complex tube formation, and endothelial pro-angiogenic support. Therefore, our results reveal the TNFα-TNFR2 axis as a crucial regulator of MSC immunological and regenerative functions.
📖 Papers frequently viewed together
10 Citations
3 Authors (Li Yan, ..., Ren-He Xu)
39 Citations
12 Citations
#1Adrian J. C. Bloor (University of Manchester)H-Index: 1
#1Adrian Bloor (University of Manchester)H-Index: 22
Last. John E.J. Rasko (RPA: Royal Prince Alfred Hospital)H-Index: 62
view all 13 authors...
The therapeutic potential of donor-derived mesenchymal stromal cells (MSCs) has been investigated in diverse diseases1, including steroid-resistant acute graft versus host disease (SR-aGvHD)2. However, conventional manufacturing approaches are hampered by challenges with scalability and interdonor variability, and clinical trials have shown inconsistent outcomes3,4. Induced pluripotent stem cells (iPSCs) have the potential to overcome these challenges, due to their capacity for multilineage diff...
20 CitationsSource
#1Sara Shamdani (French Institute of Health and Medical Research)H-Index: 3
#2Georges Uzan (French Institute of Health and Medical Research)H-Index: 35
Last. Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
view all 3 authors...
Stem cells have a vast range of functions from tissue regeneration to immunoregulation. They have the ability to modulate immune responses and change the progression of different inflammatory and autoimmune disorders. Tumor cells share many characteristics of stem/progenitor cells too. Both can inhibit effector T cells and other immune cells, while inducing regulatory T cells (T regs), thus, reducing the production of pro-inflammatory cytokines and increasing the production of anti-inflammatory ...
3 CitationsSource
#1Ghada Beldi (French Institute of Health and Medical Research)H-Index: 2
#2Maryam Khosravi (University of Paris)H-Index: 1
Last. Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
view all 7 authors...
BACKGROUND In addition to their multilineage potential, mesenchymal stem cells (MSCs) have a broad range of functions from tissue regeneration to immunomodulation. MSCs have the ability to modulate the immune response and change the progression of different inflammatory and autoimmune disorders. However, there are still many challenges to overcome before their widespread clinical administration including the mechanisms behind their immunoregulatory function. MSCs inhibit effector T cells and oth...
10 CitationsSource
#1Chi Zhang (ZJU: Zhejiang University)H-Index: 2
#2Yinuo Lin (First Affiliated Hospital of Wenzhou Medical University)H-Index: 2
Last. Hong Yu (ZJU: Zhejiang University)H-Index: 30
view all 10 authors...
Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor-β super family. It has multiple effects on development, physiology and diseases. However, the role of GDF11 in the development of mesenchymal stem cells (MSCs) is not clear. To explore the effects of GDF11 on the differentiation and pro-angiogenic activities of MSCs, mouse bone marrow-derived MSCs were engineered to overexpress GDF11 (MSCGDF11 ) and their capacity for differentiation and paracrine actions were...
3 CitationsSource
#1Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
#2Mohamed Essameldin Abdelgawad (Helwan University)H-Index: 7
Last. Georges Uzan (French Institute of Health and Medical Research)H-Index: 35
view all 8 authors...
BACKGROUND Endothelial progenitor cells (EPCs) are non-differentiated endothelial cells (ECs) present in blood circulation that are involved in neo-vascularization and correction of damaged endothelial sites. Since EPCs from patients with vascular disorders are impaired and inefficient, allogenic sources from adult or cord blood are considered as good alternatives. However, due to the reaction of immune system against allogenic cells which usually lead to their elimination, we focused on the exa...
12 CitationsSource
#1Selma Maacha (Qatar Airways)H-Index: 4
#2Heba Sidahmed (Qatar Airways)H-Index: 3
Last. Chiara Cugno (Qatar Airways)H-Index: 6
view all 7 authors...
The role of the mesenchymal stromal cell- (MSC-) derived secretome is becoming increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous tissue repair processes as well as its effective regulation of the immune system, mimicking the therapeutic effects produced by the MSCs. The secretome is a composite product secreted by MSC in vitro (in conditioned medium) and in vivo (in the extracellular milieu), consisting of a protein soluble fraction (mostly growth fac...
25 CitationsSource
#1Naoki Yamamoto (Tokyo Medical and Dental University)H-Index: 86
#2Takuya Oyaizu (Tokyo Medical and Dental University)H-Index: 4
Last. Kazuyoshi Yagishita (Tokyo Medical and Dental University)H-Index: 25
view all 7 authors...
Hyperbaric oxygen (HBO) treatment promotes early recovery from muscle injury. Reactive oxygen species (ROS) upregulation is a key mechanism of HBO, which produces high O2 content in tissues through increased dissolution of oxygen at high pressure. Nitric oxide (NO), a type of ROS, generally stabilizes hypoxia-inducible factor (HIF) 1α and stimulates secretion of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) from endothelial cells and macrophages, which then ...
8 CitationsSource
#1Afsoon Afshari (Shiraz University of Medical Sciences)H-Index: 5
#2Sara Shamdani (French Institute of Health and Medical Research)H-Index: 3
Last. Negar Azarpira (Shiraz University of Medical Sciences)H-Index: 27
view all 5 authors...
Due to the prominent role of the liver in the body and detoxification, its functionality can be affected in an irreversible manner by diseases. This phenomenon renders the liver to stop working, leading to morbidity and mortality. Therefore, liver transplantation is the only way to tackle this issue.In order to compensate for the lack of adequate healthy liver tissue for transplantation, therapeutic approaches such as hepatocyte transplantation have been proposed as an alternative. Recognizing t...
9 CitationsSource
#1Mi-Lan Kang (Yonsei University)H-Index: 4
#2Hye-Seon Kim (Yonsei University)H-Index: 2
Last. Hak-Joon Sung (Yonsei University)H-Index: 25
view all 13 authors...
Angiogenesis is stimulated by nitric oxide (NO) production in endothelial cells (ECs). Although proangiogenic actions of human mesenchymal stem cells (hMSCs) have been extensively studied, the mechanistic role of NO in this action remains obscure. Here, we used a gelatin hydrogel that releases NO upon crosslinking by a transglutaminase reaction (“NO gel”). Then, the source-specific behaviors of bone marrow versus adipose tissue-derived hMSCs (BMSCs versus ADSCs) were monitored in the NO gels. NO...
4 CitationsSource
#1Zhenhua Liu (Southern Medical University)H-Index: 4
#2Peng Wang (SYSU: Sun Yat-sen University)H-Index: 11
Last. Huiyong Shen (SYSU: Sun Yat-sen University)H-Index: 14
view all 9 authors...
Objective. To investigate the adipogenic differentiation capacity of mesenchymal stem cells (MSCs) from ankylosing spondylitis (AS) patients and explore the mechanism of abnormal MSC adipogenesis in AS. Methods. MSCs from patients with AS (ASMSCs) and healthy donors (HDMSCs) were cultured in adipogenic differentiation medium for up to 21 days. Adipogenic differentiation was determined using oil red O (ORO) staining and quantification and was confirmed by assessing adipogenic marker expression (P...
3 CitationsSource
Cited By6
#1Yang Yang (UM: University of Macau)H-Index: 2
#2Sahidul Islam (UM: University of Macau)H-Index: 1
Last. Xin Chen (UM: University of Macau)H-Index: 37
view all 4 authors...
Immune checkpoint inhibitors (ICIs), including anti-CTLA-4 (cytotoxic T lymphocyte antigen-4) and anti-PD-1/PD-L1 (programmed death-1/programmed death-ligand 1), represent a turning point in the cancer immunotherapy. However, only a minor fraction of patients could derive benefit from such therapy. Therefore, new strategies targeting additional immune regulatory mechanisms are urgently needed. CD4+Foxp3+ regulatory T cells (Tregs) represent a major cellular mechanism in cancer immune evasion. Th...
#1David García-Bernal (University of Murcia)H-Index: 21
#2Mariano García-Arranz (UAM: Autonomous University of Madrid)H-Index: 24
Last. Agustín G. Zapata (Complutense University of Madrid)H-Index: 57
view all 13 authors...
Mesenchymal stromal cells (MSCs) currently constitute the most frequently used cell type in advanced therapies with different purposes, most of which are related with inflammatory processes. Although the therapeutic efficacy of these cells has been clearly demonstrated in different disease animal models and in numerous human phase I/II clinical trials, only very few phase III trials using MSCs have demonstrated the expected potential therapeutic benefit. On the other hand, numerous controversial...
#1Mahsa Nouri Barkestani (French Institute of Health and Medical Research)H-Index: 2
#2Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
Last. Sara Shamdani (French Institute of Health and Medical Research)H-Index: 3
view all 4 authors...
Due to the current lack of innovative and effective therapeutic approaches, tissue engineering (TE) has attracted much attention during the last decades providing new hopes for the treatment of sev...
#1Dixin Cui (Sichuan University)H-Index: 5
#2Sihan Yu (Sichuan University)
Last. Mian Wan (Sichuan University)H-Index: 9
view all 8 authors...
Dental caries and trauma always lead to pulp necrosis and subsequent root development arrest of young permanent teeth. The traditional treatment, apexification, with absence of further root formation, results in abnormal root morphology and compromises long-term prognosis. Regeneration endodontics procedures (REPs) have been developed and considered as an alternative strategy for management of immature permanent teeth with pulpal necrosis, including cell-free REPs and cell-based REPs. Cell-free ...
#1Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
#2Sara Shamdani (French Institute of Health and Medical Research)H-Index: 3
Last. Georges Uzan (French Institute of Health and Medical Research)H-Index: 35
view all 4 authors...
Mesenchymal stem/stromal cells can modulate the effector immune cells especially T lymphocytes. Due to this important feature, they can regulate the development of a variety of disorders including inflammatory and autoimmune disorders, cancers, and transplantation outcomes. One of the most important MSC immunoregulatory functions is their capacity to convert conventional T cells into regulatory T cells. Several mechanisms, mostly related to MSCs but not T cells, have been shown essential for thi...
1 CitationsSource
#1Yu Y (Peking Union Medical College)H-Index: 1
#2Valderrama Av (French Institute of Health and Medical Research)H-Index: 1
Last. Estelle Oberlin (French Institute of Health and Medical Research)H-Index: 7
view all 6 authors...
Mesenchymal stem cells (MSCs) exhibit active abilities to suppress or modulate deleterious immune responses by various molecular mechanisms. These cells are the subject of major translational efforts as cellular therapies for immune-related diseases and transplantations. Plenty of preclinical studies and clinical trials employing MSCs have shown promising safety and efficacy outcomes and also shed light on the modifications in the frequency and function of regulatory T cells (T regs). Neverthele...
1 CitationsSource
#1Mahsa Nouri Barkestani (French Institute of Health and Medical Research)H-Index: 2
#2Sara Shamdani (French Institute of Health and Medical Research)H-Index: 3
Last. Sina Naserian (French Institute of Health and Medical Research)H-Index: 10
view all 7 authors...
BACKGROUND Bone marrow derived endothelial progenitor cells (EPCs) are immature endothelial cells (ECs) involved in neo-angiogenesis and endothelial homeostasis and are considered as a circulating reservoir for endothelial repair. Many studies showed that EPCs from patients with cardiovascular pathologies are impaired and insufficient; hence, allogenic sources of EPCs from adult or cord blood are considered as good choices for cell therapy applications. However, allogenic condition increases the...
3 CitationsSource